EXOME REPORT: Novel mutation in ATP6V1B2 segregating with autosomal dominant epilepsy, intellectual disability and mild gingival and nail abnormalities.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 17 04 2019
revised: 02 10 2019
accepted: 20 10 2019
pubmed: 28 10 2019
medline: 2 12 2020
entrez: 27 10 2019
Statut: ppublish

Résumé

Mutations in ATP6V1B2, which encodes the B2 subunit of the vacuolar H + ATPase have previously been associated with Zimmermann-Laband syndrome 2 (ZLS2) and deafness-onychodystrophy (DDOD) syndrome. Recently epilepsy has also been described as a potentially associated phenotype. Here we further uncover the role of ATP61VB2 in epilepsy and report autosomal dominant inheritance of a novel missense variant in ATP6V1B2 in a large Polish family with relatively mild gingival and nail problems, no phalangeal hypoplasia and with generalized epilepsy. In light of our findings and review of the literature, we propose that the ATP6V1B2 gene should be considered in families with autosomal dominant epilepsy both with or without intellectual disability, and that presence of subtle gingival and nail problems may be another characteristic calling card of affected individuals with ATP6V1B2 mutations.

Identifiants

pubmed: 31655144
pii: S1769-7212(19)30275-7
doi: 10.1016/j.ejmg.2019.103799
pii:
doi:

Substances chimiques

Vacuolar Proton-Translocating ATPases EC 3.6.1.-
ATP6V1B2 protein, human EC 7.1.2.2

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103799

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Authors do not have any conflict of interest.

Auteurs

Marie Shaw (M)

Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5000, Australia.

Anna Winczewska-Wiktor (A)

Department of Developmental Neurology, Poznan University of Medical Sciences, Poznan, Poland.

Magdalena Badura-Stronka (M)

Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.

Sunita Koirala (S)

Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5000, Australia; Central Department of Biotechnology, Tribhuvan University, Kathmandu, Nepal.

Alison Gardner (A)

Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5000, Australia.

Łukasz Kuszel (Ł)

Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.

Piotr Kowal (P)

Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.

Barbara Steinborn (B)

Department of Developmental Neurology, Poznan University of Medical Sciences, Poznan, Poland.

Monika Starczewska (M)

Department of Developmental Neurology, Poznan University of Medical Sciences, Poznan, Poland.

Sarah Garry (S)

Epilepsy Research Centre, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.

Ingrid E Scheffer (IE)

Departments of Medicine and Paediatrics, The University of Melbourne, Austin Health and Royal Children's Hospital and Florey Institute, Victoria, Australia; Epilepsy Research Centre, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.

Samuel F Berkovic (SF)

Epilepsy Research Centre, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.

Jozef Gecz (J)

Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5000, Australia; Robinson Research Institute, The University of Adelaide, Adelaide, SA, 5000, Australia; Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia. Electronic address: jozef.gecz@adelaide.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH